Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

UC.145 may be a new biomarker for predicting gastric cancer.

GI197111X is best dissolved in Capmul MCM for trials.

Vesicles made of behenyltrimethylammonium chloride and stearic acid can triple the skin absorption of hinokitiol, which may help with hair growth.

JAK inhibitors offer new hope for treating severe alopecia areata.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Platelet-rich plasma (PRP) is an effective treatment for lichen planopilaris.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Betulinic acid can help treat hepatitis C by stopping virus replication.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.